Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/12/2001 | CA2396210A1 Method for cloning animals with targetted genetic alterations by transfer_of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells |
07/12/2001 | CA2396149A1 Transduction of recombinases for inducible gene targeting |
07/12/2001 | CA2396068A1 Antisense antibacterial cell division composition and method |
07/12/2001 | CA2396040A1 Novel bacterial genes and proteins that are essential for cell viability and their uses |
07/12/2001 | CA2395945A1 Novel chimeric proteins and methods for using the same |
07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
07/12/2001 | CA2395742A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
07/12/2001 | CA2395636A1 Novel colloid synthetic vectors for gene therapy |
07/12/2001 | CA2395625A1 Progenitor cell preservation factors and related methods and products |
07/12/2001 | CA2395341A1 Method of analyzing a nucleic acid |
07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
07/12/2001 | CA2394730A1 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
07/12/2001 | CA2392844A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
07/12/2001 | CA2388566A1 Mutm orthologue and uses thereof |
07/12/2001 | CA2329318A1 Transgenic animal model of basal cell carcinoma |
07/12/2001 | CA2328634A1 Assay method |
07/11/2001 | EP1114867A1 Transcription regulatory sequences derived from Chlamydomonas reinhardtii |
07/11/2001 | EP1114866A2 Plasmids for the production of transgenic plants that are modified in habit and yield |
07/11/2001 | EP1114865A1 Production of human parathyroid hormone |
07/11/2001 | EP1114864A2 Mammalian cell surface antigens, related reagents |
07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
07/11/2001 | EP1114859A1 IMMOBILIZED cDNA LIBRARIES |
07/11/2001 | EP1114830A1 Cerebral organic anion transporter and its gene |
07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
07/11/2001 | EP1114827A1 Novel nucleic acid base pair |
07/11/2001 | EP1114320A2 A system for cell-based screening |
07/11/2001 | EP1114317A2 Signal detection techniques for the detection of analytes |
07/11/2001 | EP1114314A1 Device comprising a plurality of analysis sites on a support |
07/11/2001 | EP1114189A1 Recombinant newcastle disease virus rna expression systems and vaccines |
07/11/2001 | EP1114187A1 Geometrical and hierarchical classification based on gene expression |
07/11/2001 | EP1114185A1 Method of isolating primer extension products with modular oligonucleotides |
07/11/2001 | EP1114184A2 Molecular cloning using rolling circle amplification |
07/11/2001 | EP1114183A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
07/11/2001 | EP1114182A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
07/11/2001 | EP1114178A1 Nucleic acid sequencing with solid phase capturable terminators |
07/11/2001 | EP1114177A1 Assay member and method for its manufacture |
07/11/2001 | EP1114176A1 Process for enzymatically modifying pectin |
07/11/2001 | EP1114174A1 Process for making polycarboxylic acids |
07/11/2001 | EP1114173A2 Synthesis of vanillin from a carbon source |
07/11/2001 | EP1114172A1 Transfer method for specific cellular localisation of nucleic acids |
07/11/2001 | EP1114171A1 Methods for treatment of degenerative retinal diseases |
07/11/2001 | EP1114170A2 Maize replication protein a |
07/11/2001 | EP1114169A1 Methods for producing genetically modified plants, plant materials and plant products produced thereby |
07/11/2001 | EP1114168A2 Uracil permease from arabidopsis as herbicidal target gene |
07/11/2001 | EP1114167A1 Salicylic acid inducible genes and promoters from tobacco |
07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
07/11/2001 | EP1114165A1 Aspergillus tubigensis polygalacturonase |
07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
07/11/2001 | EP1114163A2 Engineering beta-ketoacyl acp synthase for novel substrate specificity |
07/11/2001 | EP1114162A1 Genes coding for flavone synthases |
07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
07/11/2001 | EP1114155A2 Human gpcr proteins |
07/11/2001 | EP1114154A2 Compositions and methods for the treatment of immune related diseases |
07/11/2001 | EP1114153A2 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof |
07/11/2001 | EP1114152A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/11/2001 | EP1114151A1 G protein-coupled receptor agonists or antagonists |
07/11/2001 | EP1114150A1 Monolithic matrix for separating nucleic acids by reverse-phase ion-pair high performance liquid chromatography |
07/11/2001 | EP1114149A1 Rnase p polypeptides |
07/11/2001 | EP1114148A1 System for the rapid manipulation of nucleic acid sequences |
07/11/2001 | EP1114147A1 A 2,6-$g(b)-D-FRUCTAN HYDROLASE ENZYME AND PROCESSES FOR USING THE ENZYME |
07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
07/11/2001 | EP1114145A1 Topa |
07/11/2001 | EP1114143A1 Streptococcal c beta protein compositions |
07/11/2001 | EP1114142A1 Interleukin 17-like receptor protein |
07/11/2001 | EP1114063A2 A method of producing a functional immunoglobulin superfamily protein |
07/11/2001 | EP1114062A1 MODIFIED $i(E. COLI) ENTEROTOXIN II SIGNAL PEPTIDE AND A MICROORGANISM EXPRESSING A FUSION PROTEIN OF SAID PEPTIDE AND A HETEROLOGOUS PROTEIN |
07/11/2001 | EP1114059A1 Regulation of immune responses by attractin |
07/11/2001 | EP1114058A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof |
07/11/2001 | EP1113986A2 Inventory control |
07/11/2001 | EP1113820A1 Expandible microparticle intracellular delivery system |
07/11/2001 | EP1113810A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
07/11/2001 | EP1113808A1 A method of treatment and agents useful for same |
07/11/2001 | EP1027121A4 Improved liquid chromatographic media for polynucleotide separation |
07/11/2001 | EP1017466A4 Polynucleotide separations on nonporous polymer beads |
07/11/2001 | EP0970240A4 Artificial mismatch hybridization |
07/11/2001 | EP0969865A4 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
07/11/2001 | EP0866868B1 Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus and mutant enzymes thereof with exonuclease activity removed |
07/11/2001 | EP0731808B1 Nucleosides and oligonucleotides containing boron clusters |
07/11/2001 | EP0600018B1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
07/11/2001 | EP0495064B1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
07/11/2001 | CN1303442A Method |
07/11/2001 | CN1303441A Cotton cells, plants and seeds genetically engineered to express insecticidal and fungicidal chitin binding proteins (lectins) |
07/11/2001 | CN1303440A Expression system for producing proteins |
07/11/2001 | CN1303439A Novel constructs for controlled expression of recombinant proteins in prokaryotic cells |
07/11/2001 | CN1303437A Serine protease variants having amino acid deletions and substitutions |
07/11/2001 | CN1303436A Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
07/11/2001 | CN1303434A Genetic method for producing riboflavin |
07/11/2001 | CN1303433A Recombinant potyvirus construct and use thereof |
07/11/2001 | CN1303432A Novel insecticidal toxins from i(xenorhabdus nematophilus) and nucleic acid sequences coding therefor |
07/11/2001 | CN1303431A Humanized antibody against human tissue factor (TF) and process for constructing humanized antibody |
07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
07/11/2001 | CN1303429A Therapeutic applications of mature FLINT (mFLINT) polypeptides or OPG3, member of TNF receptor superfamily |
07/11/2001 | CN1303428A 人蛋白c多肽 Human protein peptide c |
07/11/2001 | CN1303426A Novel methods for rescue of RNA viruses |